Arvind Sahu
Cited by
Cited by
Structure and biology of complement protein C3, a connecting link between innate and acquired immunity
A Sahu, JD Lambris
Immunological reviews 180, 35-48, 2001
Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
A Sahu, BK Kay, JD Lambris
The Journal of Immunology 157 (2), 884-891, 1996
Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
A Sahu, JD Lambris
Immunopharmacology 49 (1-2), 133-148, 2000
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation
B Nilsson, R Larsson, J Hong, G Elgue, KN Ekdahl, A Sahu, JD Lambris
Blood, The Journal of the American Society of Hematology 92 (5), 1661-1667, 1998
Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement …
A Sahu, SN Isaacs, AM Soulika, JD Lambris
The Journal of Immunology 160 (11), 5596-5604, 1998
Multiple forms of complement C3 in trout that differ in binding to complement activators
JO Sunyer, IK Zarkadis, A Sahu, JD Lambris
Proceedings of the National Academy of Sciences 93 (16), 8546-8551, 1996
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
X Sun, CD Funk, C Deng, A Sahu, JD Lambris, WC Song
Proceedings of the National Academy of Sciences 96 (2), 628-633, 1999
Solution structure of Compstatin, a potent complement inhibitor
D Morikis, N Assa‐Munt, A Sahu, JD Lambris
Protein Science 7 (3), 619-627, 1998
Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation
A Sahu, TR Kozel, MK Pangburn
Biochemical Journal 302 (2), 429-436, 1994
Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin
A Sahu, AM Soulika, D Morikis, L Spruce, WT Moore, JD Lambris
The Journal of Immunology 165 (5), 2491-2499, 2000
In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC
J Lubinski, L Wang, D Mastellos, A Sahu, JD Lambris, HM Friedman
The Journal of experimental medicine 190 (11), 1637-1646, 1999
Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts
AE Fiane, TE Mollnes, V Videm, T Hovig, K Høgåsen, OJ Mellbye, ...
Xenotransplantation 6 (1), 52-65, 1999
Identification of multiple sites of interaction between heparin and the complement system
A Sahu, MK Panoburn
Molecular immunology 30 (7), 679-684, 1993
Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
I Kostavasili, A Sahu, HM Friedman, RJ Eisenberg, GH Cohen, ...
The Journal of Immunology 158 (4), 1763-1771, 1997
Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b
A Sahu, N Rawal, MK Pangburn
Biochemical pharmacology 57 (12), 1439-1446, 1999
Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons
AM Soulika, MM Khan, T Hattori, FW Bowen, BA Richardson, CE Hack, ...
Clinical immunology 96 (3), 212-221, 2000
Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3
A Sahu, D Morikis, JD Lambris
Molecular immunology 39 (10), 557-566, 2003
Viral mimicry of the complement system
J Bernet, J Mullick, AK Singh, A Sahu
Journal of biosciences 28 (3), 249-264, 2003
Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220
MR Sarrias, S Franchini, G Canziani, E Argyropoulos, WT Moore, A Sahu, ...
The Journal of Immunology 167 (3), 1490-1499, 2001
The chemistry and biology of C3, C4, and C5
JD Lambris, A Sahu, R Wetsel
The human complement system in health and disease 83, 1998
The system can't perform the operation now. Try again later.
Articles 1–20